首页 > 最新文献

Maturitas最新文献

英文 中文
Comment on the paper “Effect of duration of hormonal contraceptive use on breast cancer risk: a systematic review and meta-analysis of cohort studies” 对“激素避孕药使用持续时间对乳腺癌风险的影响:队列研究的系统回顾和荟萃分析”论文的评论
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-28 DOI: 10.1016/j.maturitas.2025.108800
Wanzhi Jiang , Qinghong Yu
{"title":"Comment on the paper “Effect of duration of hormonal contraceptive use on breast cancer risk: a systematic review and meta-analysis of cohort studies”","authors":"Wanzhi Jiang , Qinghong Yu","doi":"10.1016/j.maturitas.2025.108800","DOIUrl":"10.1016/j.maturitas.2025.108800","url":null,"abstract":"","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"204 ","pages":"Article 108800"},"PeriodicalIF":3.6,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145684401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to the letter titled “Comment on the paper Effect of duration of hormonal contraceptive use on breast cancer risk: a systematic review and meta-analysis of cohort studies” 回复题为“对《激素避孕药使用持续时间对乳腺癌风险的影响:队列研究的系统回顾和荟萃分析》一文的评论”。
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-28 DOI: 10.1016/j.maturitas.2025.108801
Carmen Sayon-Orea , Miguel A. Martínez-González
{"title":"Reply to the letter titled “Comment on the paper Effect of duration of hormonal contraceptive use on breast cancer risk: a systematic review and meta-analysis of cohort studies”","authors":"Carmen Sayon-Orea , Miguel A. Martínez-González","doi":"10.1016/j.maturitas.2025.108801","DOIUrl":"10.1016/j.maturitas.2025.108801","url":null,"abstract":"","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"204 ","pages":"Article 108801"},"PeriodicalIF":3.6,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145663099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative hyperglycemia and postoperative adverse events in geriatric hip fracture surgery: Glycemic thresholds and exposure persistence 老年髋部骨折手术的术前高血糖和术后不良事件:血糖阈值和暴露持久性
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-26 DOI: 10.1016/j.maturitas.2025.108791
Yazhou Liu , Ying Yang , Yuhao Li , Zhe Yang , Xiaodong Yang

Background

Preoperative blood glucose levels are closely related to the occurrence of postoperative adverse events for geriatric patients undergoing surgery for hip fracture. However, the specific association between preoperative blood glucose levels and postoperative pressure ulcers (PU), postoperative delirium (POD), and prolonged length of stay (LOS) requires further investigation.

Methods

This retrospective cohort study included hip fracture patients from 2017 to 2024. Preoperative blood glucose levels were analyzed both as a continuous variable and as a categorical variable to examine their association with postoperative PU, POD, and LOS. Statistical analyses were conducted using multivariable logistic regression, propensity score matching analysis and generalized linear models.

Results

The results showed that for each 1 mmol/L increase in preoperative blood glucose, the risk of developing postoperative pressure ulcers and delirium increased by 21 % and 28 %, respectively, while hospital stay was prolonged by 0.54 days. Notably, in subgroups of male patients, those aged 70–79 years, those with no prior history of hypertension or delirium, those with surgical time ≥ 1.6 h, and those with time from admission to surgery >5 days, the positive correlation between preoperative blood glucose levels and PU and POD was even stronger. When preoperative blood glucose levels exceeded 6.09 mmol/L (for PU and LOS) and 6.17 mmol/L (for POD), timely intervention became crucial.

Conclusions

Preoperative hyperglycemia is significantly associated with postoperative PU, POD, and LOS in geriatric patients undergoing surgery for hip fracture. Early intervention, particularly glucose management for specific high-risk groups, may help reduce the incidence of adverse events.
背景:老年髋部骨折患者术前血糖水平与术后不良事件的发生密切相关。然而,术前血糖水平与术后压疮(PU)、术后谵妄(POD)和住院时间延长(LOS)之间的具体关系需要进一步研究。方法回顾性队列研究纳入2017 - 2024年髋部骨折患者。术前血糖水平作为连续变量和分类变量进行分析,以检查其与术后PU、POD和LOS的关系。统计分析采用多变量logistic回归、倾向评分匹配分析和广义线性模型。结果术前血糖每升高1 mmol/L,术后发生压疮和谵妄的风险分别增加21%和28%,住院时间延长0.54 d。值得注意的是,在男性患者亚组中,年龄70 ~ 79岁、既往无高血压或谵妄病史、手术时间≥1.6 h、入院至手术时间≥5天的患者,术前血糖水平与PU、POD的正相关性更强。当术前血糖水平超过6.09 mmol/L (PU和LOS)和6.17 mmol/L (POD)时,及时干预至关重要。结论老年髋部骨折患者术后高血糖与术后PU、POD、LOS显著相关。早期干预,特别是针对特定高危人群的血糖管理,可能有助于减少不良事件的发生。
{"title":"Preoperative hyperglycemia and postoperative adverse events in geriatric hip fracture surgery: Glycemic thresholds and exposure persistence","authors":"Yazhou Liu ,&nbsp;Ying Yang ,&nbsp;Yuhao Li ,&nbsp;Zhe Yang ,&nbsp;Xiaodong Yang","doi":"10.1016/j.maturitas.2025.108791","DOIUrl":"10.1016/j.maturitas.2025.108791","url":null,"abstract":"<div><h3>Background</h3><div>Preoperative blood glucose levels are closely related to the occurrence of postoperative adverse events for geriatric patients undergoing surgery for hip fracture. However, the specific association between preoperative blood glucose levels and postoperative pressure ulcers (PU), postoperative delirium (POD), and prolonged length of stay (LOS) requires further investigation.</div></div><div><h3>Methods</h3><div>This retrospective cohort study included hip fracture patients from 2017 to 2024. Preoperative blood glucose levels were analyzed both as a continuous variable and as a categorical variable to examine their association with postoperative PU, POD, and LOS. Statistical analyses were conducted using multivariable logistic regression, propensity score matching analysis and generalized linear models.</div></div><div><h3>Results</h3><div>The results showed that for each 1 mmol/L increase in preoperative blood glucose, the risk of developing postoperative pressure ulcers and delirium increased by 21 % and 28 %, respectively, while hospital stay was prolonged by 0.54 days. Notably, in subgroups of male patients, those aged 70–79 years, those with no prior history of hypertension or delirium, those with surgical time ≥ 1.6 h, and those with time from admission to surgery &gt;5 days, the positive correlation between preoperative blood glucose levels and PU and POD was even stronger. When preoperative blood glucose levels exceeded 6.09 mmol/L (for PU and LOS) and 6.17 mmol/L (for POD), timely intervention became crucial.</div></div><div><h3>Conclusions</h3><div>Preoperative hyperglycemia is significantly associated with postoperative PU, POD, and LOS in geriatric patients undergoing surgery for hip fracture. Early intervention, particularly glucose management for specific high-risk groups, may help reduce the incidence of adverse events.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"204 ","pages":"Article 108791"},"PeriodicalIF":3.6,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145618324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Handgrip strength in patients with subclinical hypothyroidism or subclinical hyperthyroidism compared with that in euthyroid individuals: A systematic review and meta-analysis 亚临床甲状腺功能减退或亚临床甲状腺功能亢进患者与甲状腺功能正常者的握力比较:一项系统综述和荟萃分析
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-25 DOI: 10.1016/j.maturitas.2025.108780
Ana M. Fernández-Alonso , Pascual García-Alfaro , Faustino R. Pérez-López

Objective

This systematic review and meta-analysis assessed handgrip strength in patients with either subclinical hypothyroidism or subclinical hyperthyroidism as compared with euthyroid individuals.

Methods

We searched in Web of Science, Scopus, and PubMed databases for information about cross-sectional studies comparing subclinical hypothyroid or subclinical hyperthyroid patients and euthyroid control individuals. The quality of included studies was evaluated with the Newcastle-Ottawa Scale. Random-effect meta-analyses were conducted to minimize the effects of uncertainty associated with inter-study variability. Results are reported as mean differences, standardized mean differences, or odds ratios with 95 % confidence intervals. Heterogeneity between studies was assessed using I2 and τ2 statistics.

Results

Seven studies with low or moderate risk of bias were eligible for inclusion in the meta-analysis of patients with either subclinical hypothyroidism or hyperthyroidism compared with euthyroid individuals. The meta-analysis of five studies of patients with subclinical hypothyroidism showed they had lower handgrip strength (standardized mean difference: −0.61, 95 % confidence interval −1.15, −0.07; p = 0.03) and lower thyroxine levels (standardized mean difference: −0.52, 95 % confidence interval −0.87, −0.16; p = 0.004) than euthyroid individuals. They also had a higher body mass index (mean difference: 1.05, 95 % confidence interval: 0.17, 1.93, p = 0.02), higher total cholesterol (standardized mean difference 0.28, 95 % confidence interval 0.09, 0.46, p = 0.003) and lower thyroxine levels (standardized mean difference: −0.52, 95 % confidence interval −0.87, −0.16; p = 0.004), and a higher risk of sarcopenia (odds ratio: 2.12, 95 % confidence interval 1.40, 3.22, p = 0.0004) than euthyroid individuals. The meta-analyses of four studies of patients with subclinical hyperthyroidism did not show differences in measured outcomes compared with euthyroid individuals.

Conclusions

Patients with subclinical hypothyroidism have lower handgrip strength than euthyroid individuals. There was no significant difference in handgrip strength between patients with subclinical hyperthyroidism and euthyroid individuals.
PROSPERO registration: CRD420251004586.
目的:本系统综述和荟萃分析评估了亚临床甲状腺功能减退或亚临床甲状腺功能亢进患者与甲状腺功能正常者的握力差异。方法:我们在Web of Science、Scopus和PubMed数据库中检索亚临床甲状腺功能减退或亚临床甲状腺功能亢进患者与甲状腺功能正常对照个体的横断面研究信息。纳入研究的质量用纽卡斯尔-渥太华量表进行评价。进行随机效应荟萃分析以尽量减少与研究间变异性相关的不确定性的影响。结果以平均差异、标准化平均差异或95%置信区间的优势比报告。采用I2和τ2统计量评估研究间的异质性。结果:7项低或中等偏倚风险的研究符合纳入亚临床甲状腺功能减退或甲状腺功能亢进患者与甲状腺功能正常患者的meta分析。对亚临床甲状腺功能减退患者的5项研究的荟萃分析显示,他们的握力(标准化平均差值:-0.61,95%可信区间-1.15,-0.07;p = 0.03)和甲状腺素水平(标准化平均差值:-0.52,95%可信区间-0.87,-0.16;p = 0.004)低于甲状腺功能正常者。与正常甲状腺个体相比,他们的体重指数更高(平均差值为1.05,95%置信区间为0.17,1.93,p = 0.02),总胆固醇更高(标准化平均差值为0.28,95%置信区间为0.09,0.46,p = 0.003),甲状腺素水平更低(标准化平均差值为-0.52,95%置信区间为-0.87,-0.16,p = 0.004),肌肉减少症的风险更高(优势比为2.12,95%置信区间为1.40,3.22,p = 0.0004)。对亚临床甲状腺功能亢进患者的四项研究的荟萃分析显示,与甲状腺功能正常的个体相比,测量结果没有差异。结论:亚临床甲状腺功能减退患者的握力低于甲状腺功能正常者。亚临床甲亢患者与甲状腺功能正常者的握力无显著差异。普洛斯彼罗注册号:CRD420251004586。
{"title":"Handgrip strength in patients with subclinical hypothyroidism or subclinical hyperthyroidism compared with that in euthyroid individuals: A systematic review and meta-analysis","authors":"Ana M. Fernández-Alonso ,&nbsp;Pascual García-Alfaro ,&nbsp;Faustino R. Pérez-López","doi":"10.1016/j.maturitas.2025.108780","DOIUrl":"10.1016/j.maturitas.2025.108780","url":null,"abstract":"<div><h3>Objective</h3><div>This systematic review and meta-analysis assessed handgrip strength in patients with either subclinical hypothyroidism or subclinical hyperthyroidism as compared with euthyroid individuals.</div></div><div><h3>Methods</h3><div>We searched in Web of Science, Scopus, and PubMed databases for information about cross-sectional studies comparing subclinical hypothyroid or subclinical hyperthyroid patients and euthyroid control individuals. The quality of included studies was evaluated with the Newcastle-Ottawa Scale. Random-effect meta-analyses were conducted to minimize the effects of uncertainty associated with inter-study variability. Results are reported as mean differences, standardized mean differences, or odds ratios with 95 % confidence intervals. Heterogeneity between studies was assessed using I<sup>2</sup> and τ<sup>2</sup> statistics.</div></div><div><h3>Results</h3><div>Seven studies with low or moderate risk of bias were eligible for inclusion in the meta-analysis of patients with either subclinical hypothyroidism or hyperthyroidism compared with euthyroid individuals. The meta-analysis of five studies of patients with subclinical hypothyroidism showed they had lower handgrip strength (standardized mean difference: −0.61, 95 % confidence interval −1.15, −0.07; <em>p</em> = 0.03) and lower thyroxine levels (standardized mean difference: −0.52, 95 % confidence interval −0.87, −0.16; <em>p</em> = 0.004) than euthyroid individuals. They also had a higher body mass index (mean difference: 1.05, 95 % confidence interval: 0.17, 1.93, <em>p</em> = 0.02), higher total cholesterol (standardized mean difference 0.28, 95 % confidence interval 0.09, 0.46, <em>p</em> = 0.003) and lower thyroxine levels (standardized mean difference: −0.52, 95 % confidence interval −0.87, −0.16; <em>p</em> = 0.004), and a higher risk of sarcopenia (odds ratio: 2.12, 95 % confidence interval 1.40, 3.22, <em>p</em> = 0.0004) than euthyroid individuals. The meta-analyses of four studies of patients with subclinical hyperthyroidism did not show differences in measured outcomes compared with euthyroid individuals.</div></div><div><h3>Conclusions</h3><div>Patients with subclinical hypothyroidism have lower handgrip strength than euthyroid individuals. There was no significant difference in handgrip strength between patients with subclinical hyperthyroidism and euthyroid individuals.</div><div>PROSPERO registration: CRD420251004586.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"204 ","pages":"Article 108780"},"PeriodicalIF":3.6,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual assault referral centers for survivors of rape in Finland – A review of their development and support for survivors 芬兰强奸幸存者的性侵犯转诊中心-对其发展和对幸存者的支持的回顾。
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-25 DOI: 10.1016/j.maturitas.2025.108787
Jenni Krogell , Katja Kero , Rauni Klami , Sari Pelkonen , Riina Korjamo
In Finland, multidisciplinary sexual assault referral centers (SARCs) primarily serve victims of rape within one month of the incident. The services are offered at no cost and are available to individuals aged 16 and over, irrespective of sex or gender, and regardless of whether they decide to report the assault to the authorities. Services consist of medical and forensic examinations, trauma support and counselling. Follow-up and treatment of sexually transmitted diseases and potential pregnancy are included.
Specialized services and standardized examination and follow-up protocols have increased the quality of forensic medical examination and samples. Trauma-informed psychosocial support services are available from the outset. Sensitive but active follow-up from the same place have improved the rape survivor's recovery.
This paper reviews the history of SARCs in Finland and the care they provide to survivors of sexual violence.
在芬兰,多学科性侵犯转诊中心(SARCs)主要为事件发生后一个月内的强奸受害者提供服务。这些服务免费提供给16岁及以上的个人,不论性别或性别,也不论他们是否决定向当局报告袭击事件。服务包括医疗和法医检查、创伤支助和咨询。性传播疾病和潜在怀孕的后续治疗也包括在内。专业服务、标准化检查和后续协议提高了法医检查和样本的质量。从一开始就提供创伤信息社会心理支持服务。来自同一地方的敏感而积极的随访改善了强奸幸存者的康复。本文回顾了芬兰红十字会的历史,以及他们为性暴力幸存者提供的护理。
{"title":"Sexual assault referral centers for survivors of rape in Finland – A review of their development and support for survivors","authors":"Jenni Krogell ,&nbsp;Katja Kero ,&nbsp;Rauni Klami ,&nbsp;Sari Pelkonen ,&nbsp;Riina Korjamo","doi":"10.1016/j.maturitas.2025.108787","DOIUrl":"10.1016/j.maturitas.2025.108787","url":null,"abstract":"<div><div>In Finland, multidisciplinary sexual assault referral centers (SARCs) primarily serve victims of rape within one month of the incident. The services are offered at no cost and are available to individuals aged 16 and over, irrespective of sex or gender, and regardless of whether they decide to report the assault to the authorities. Services consist of medical and forensic examinations, trauma support and counselling. Follow-up and treatment of sexually transmitted diseases and potential pregnancy are included.</div><div>Specialized services and standardized examination and follow-up protocols have increased the quality of forensic medical examination and samples. Trauma-informed psychosocial support services are available from the outset. Sensitive but active follow-up from the same place have improved the rape survivor's recovery.</div><div>This paper reviews the history of SARCs in Finland and the care they provide to survivors of sexual violence.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"204 ","pages":"Article 108787"},"PeriodicalIF":3.6,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145679953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cross-national evidence on frailty–depression multi-trajectories and osteoporosis risk: Findings from the ELSA and HRS cohorts 关于虚弱-抑郁多轨迹和骨质疏松风险的跨国证据:来自ELSA和HRS队列的发现
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-24 DOI: 10.1016/j.maturitas.2025.108790
Shufang Deng , Rui Xie , Wei Zhao , Zhaoheng Chen , Zeping Chen

Background

Frailty and depression commonly co-occur in older adults and may jointly elevate the risk of osteoporosis. However, evidence on their long-term multi-trajectories and impact on osteoporosis is limited, particularly across different populations.

Methods

We analyzed data from 2971 participants aged ≥50 years without osteoporosis at baseline in the English Longitudinal Study of Ageing (ELSA) and 5199 participants from the U.S. Health and Retirement Study (HRS). Group-based multi-trajectories modeling identified frailty–depression trajectories, and incident osteoporosis was ascertained through self-reported physician diagnosis during follow-up. Cox proportional hazards models estimated associations of trajectory groups with osteoporosis risk, adjusting for demographics and lifestyle factors.

Results

Over a median follow-up of 10 years in ELSA and 7.9 years in HRS, three consistent frailty–depression trajectories were identified in both cohorts—stable low, increasing moderate, and persistent high—accompanied by 220 (7.4 %) and 867 (16.7 %) incident osteoporosis cases, respectively. Compared with the stable low frailty–low depression group, the risk of osteoporosis was significantly higher for the persistent high frailty–high depression group (ELSA: HR = 2.52, 95 % CI 1.50–4.24; HRS: HR = 2.66, 95 % CI 2.12–3.35) and for the increasing moderate frailty–moderate depression group (ELSA: HR = 1.47, 95 % CI 1.03–2.09; HRS: HR = 1.45, 95 % CI 1.24–1.70).

Conclusion

Across both the UK and US cohorts, long-term multi-trajectories of frailty and depression were strongly associated with the incidence of osteoporosis. Individuals with persistent high frailty–high depression had the greatest risk, whereas those with increasing moderate frailty–moderate depression also experienced cumulative risk. Prevention should extend beyond skeletal targets to include early, integrated strategies addressing functional decline and mental health in older adults.
背景:虚弱和抑郁通常在老年人中同时发生,并可能共同增加骨质疏松症的风险。然而,关于它们的长期多轨迹和对骨质疏松症的影响的证据有限,特别是在不同的人群中。方法:我们分析了来自英国老龄化纵向研究(ELSA)的2971名≥50岁无骨质疏松症的受试者和来自美国健康与退休研究(HRS)的5199名受试者的数据。基于组的多轨迹模型确定了虚弱-抑郁轨迹,并通过随访期间自我报告的医师诊断确定了骨质疏松事件。Cox比例风险模型估计了轨迹组与骨质疏松症风险的关联,调整了人口统计学和生活方式因素。结果在ELSA组和HRS组的中位随访时间分别为10年和7.9年,在两个队列中均发现了三种一致的衰弱-抑郁轨迹——稳定的低、增加的中等和持续的高——分别伴有220例(7.4%)和867例(16.7%)骨质疏松事件。与稳定的低虚弱-低抑郁组相比,持续的高虚弱-高抑郁组(ELSA: HR = 2.52, 95% CI 1.50-4.24; HRS: HR = 2.66, 95% CI 2.12-3.35)和增加的中度虚弱-中度抑郁组(ELSA: HR = 1.47, 95% CI 1.03-2.09; HRS: HR = 1.45, 95% CI 1.24-1.70)骨质疏松的风险显著高于稳定的低虚弱-低抑郁组。结论在英国和美国的队列中,长期的多轨迹虚弱和抑郁与骨质疏松症的发生率密切相关。持续高虚弱-高抑郁的个体风险最大,而中度虚弱-中度抑郁的个体也经历了累积风险。预防应扩展到骨骼目标之外,包括针对老年人功能衰退和心理健康的早期综合战略。
{"title":"Cross-national evidence on frailty–depression multi-trajectories and osteoporosis risk: Findings from the ELSA and HRS cohorts","authors":"Shufang Deng ,&nbsp;Rui Xie ,&nbsp;Wei Zhao ,&nbsp;Zhaoheng Chen ,&nbsp;Zeping Chen","doi":"10.1016/j.maturitas.2025.108790","DOIUrl":"10.1016/j.maturitas.2025.108790","url":null,"abstract":"<div><h3>Background</h3><div>Frailty and depression commonly co-occur in older adults and may jointly elevate the risk of osteoporosis. However, evidence on their long-term multi-trajectories and impact on osteoporosis is limited, particularly across different populations.</div></div><div><h3>Methods</h3><div>We analyzed data from 2971 participants aged ≥50 years without osteoporosis at baseline in the English Longitudinal Study of Ageing (ELSA) and 5199 participants from the U.S. Health and Retirement Study (HRS). Group-based multi-trajectories modeling identified frailty–depression trajectories, and incident osteoporosis was ascertained through self-reported physician diagnosis during follow-up. Cox proportional hazards models estimated associations of trajectory groups with osteoporosis risk, adjusting for demographics and lifestyle factors.</div></div><div><h3>Results</h3><div>Over a median follow-up of 10 years in ELSA and 7.9 years in HRS, three consistent frailty–depression trajectories were identified in both cohorts—stable low, increasing moderate, and persistent high—accompanied by 220 (7.4 %) and 867 (16.7 %) incident osteoporosis cases, respectively. Compared with the stable low frailty–low depression group, the risk of osteoporosis was significantly higher for the persistent high frailty–high depression group (ELSA: HR = 2.52, 95 % CI 1.50–4.24; HRS: HR = 2.66, 95 % CI 2.12–3.35) and for the increasing moderate frailty–moderate depression group (ELSA: HR = 1.47, 95 % CI 1.03–2.09; HRS: HR = 1.45, 95 % CI 1.24–1.70).</div></div><div><h3>Conclusion</h3><div>Across both the UK and US cohorts, long-term multi-trajectories of frailty and depression were strongly associated with the incidence of osteoporosis. Individuals with persistent high frailty–high depression had the greatest risk, whereas those with increasing moderate frailty–moderate depression also experienced cumulative risk. Prevention should extend beyond skeletal targets to include early, integrated strategies addressing functional decline and mental health in older adults.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"204 ","pages":"Article 108790"},"PeriodicalIF":3.6,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145618393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of socioeconomic position and depression with frailty among older adults: Cross-sectional evidence from 17 countries 老年人的社会经济地位和抑郁与虚弱的关系:来自17个国家的横断面证据
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-24 DOI: 10.1016/j.maturitas.2025.108788
Yizhong Ye , Lushaobo Shi , Zengping Shi , Qinqin Jiang , Hongli Yan , Chunquan Ou , Chen Mao , Dong Wang

Objectives

This study describes the cross-national variation in socioeconomic disparities in frailty among older adults, assesses whether depression mediates the relationship between socioeconomic position and frailty, and examines the extent of the interactive or joint effects of depression and socioeconomic position on frailty.

Study design

A cross-sectional analysis was conducted using population-based data from five aging cohorts across 17 countries. Frailty was assessed using the modified Fried Frailty Phenotype scale, which comprises five domains. Educational level and total household income were used to measure socioeconomic position. Multivariable logistic regression was used to calculate the odds ratios and 95 % confidence intervals for the associations, and pooled odds ratios were estimated using a random-effect meta-analysis. Mediation and interaction analyses explored the association between socioeconomic position, depression, and frailty.

Results

Among the 104,136 adults (mean age 64.29 years), 27,115 were frail. The prevalence of frailty varied widely across countries (Switzerland, 6.00 %; India, 46.51 %). Participants occupying a low socioeconomic position had a significantly higher risk of frailty than those in higher socioeconomic positions, with the association more pronounced in high-income countries. Depression mediated 30.9 % of the association between socioeconomic position and frailty. A significant additive interaction of low socioeconomic position and depression on frailty (1.98) was observed. Individuals occupying a low socioeconomic position who had depression had a markedly higher risk of frailty than those in a high socioeconomic position and no depression.

Conclusions

Socioeconomic disparities in frailty vary across countries. The combined effects of socioeconomic position and depression highlight the need for integrated interventions to reduce frailty and promote healthy, equitable aging globally.
目的本研究描述了老年人虚弱的社会经济差异的跨国差异,评估抑郁是否介导了社会经济地位和虚弱之间的关系,并检验了抑郁和社会经济地位对虚弱的相互作用或联合作用的程度。研究设计采用来自17个国家的5个老龄化队列的人口数据进行横断面分析。脆弱性采用改良的Fried脆弱性表型量表进行评估,该量表包括五个域。教育水平和家庭总收入被用来衡量社会经济地位。使用多变量逻辑回归计算相关的优势比和95%置信区间,并使用随机效应荟萃分析估计合并优势比。中介和交互分析探讨了社会经济地位、抑郁和脆弱之间的关系。结果104,136名成人(平均年龄64.29岁)中,27,115名体弱。不同国家的虚弱患病率差异很大(瑞士,6.00%;印度,46.51%)。社会经济地位低的参与者比社会经济地位高的参与者有更高的虚弱风险,这种关联在高收入国家更为明显。抑郁介导了社会经济地位与虚弱之间30.9%的关联。低社会经济地位和抑郁对虚弱有显著的加性交互作用(1.98)。社会经济地位低但有抑郁症的个体比社会经济地位高但没有抑郁症的个体有明显更高的虚弱风险。结论:不同国家在虚弱方面的社会经济差异不同。社会经济地位和抑郁症的综合影响突出表明,需要采取综合干预措施,在全球范围内减少脆弱性,促进健康、公平的老龄化。
{"title":"Associations of socioeconomic position and depression with frailty among older adults: Cross-sectional evidence from 17 countries","authors":"Yizhong Ye ,&nbsp;Lushaobo Shi ,&nbsp;Zengping Shi ,&nbsp;Qinqin Jiang ,&nbsp;Hongli Yan ,&nbsp;Chunquan Ou ,&nbsp;Chen Mao ,&nbsp;Dong Wang","doi":"10.1016/j.maturitas.2025.108788","DOIUrl":"10.1016/j.maturitas.2025.108788","url":null,"abstract":"<div><h3>Objectives</h3><div>This study describes the cross-national variation in socioeconomic disparities in frailty among older adults, assesses whether depression mediates the relationship between socioeconomic position and frailty, and examines the extent of the interactive or joint effects of depression and socioeconomic position on frailty.</div></div><div><h3>Study design</h3><div>A cross-sectional analysis was conducted using population-based data from five aging cohorts across 17 countries. Frailty was assessed using the modified Fried Frailty Phenotype scale, which comprises five domains. Educational level and total household income were used to measure socioeconomic position. Multivariable logistic regression was used to calculate the odds ratios and 95 % confidence intervals for the associations, and pooled odds ratios were estimated using a random-effect meta-analysis. Mediation and interaction analyses explored the association between socioeconomic position, depression, and frailty.</div></div><div><h3>Results</h3><div>Among the 104,136 adults (mean age 64.29 years), 27,115 were frail. The prevalence of frailty varied widely across countries (Switzerland, 6.00 %; India, 46.51 %). Participants occupying a low socioeconomic position had a significantly higher risk of frailty than those in higher socioeconomic positions, with the association more pronounced in high-income countries. Depression mediated 30.9 % of the association between socioeconomic position and frailty. A significant additive interaction of low socioeconomic position and depression on frailty (1.98) was observed. Individuals occupying a low socioeconomic position who had depression had a markedly higher risk of frailty than those in a high socioeconomic position and no depression.</div></div><div><h3>Conclusions</h3><div>Socioeconomic disparities in frailty vary across countries. The combined effects of socioeconomic position and depression highlight the need for integrated interventions to reduce frailty and promote healthy, equitable aging globally.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"204 ","pages":"Article 108788"},"PeriodicalIF":3.6,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145618321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fezolinetant compared with elinzanetant for the treatment of vasomotor symptoms associated with menopause: A matching-adjusted indirect comparison 非唑啉奈坦与依兰那坦治疗与更年期相关的血管舒缩症状的比较:一个匹配调整的间接比较。
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-24 DOI: 10.1016/j.maturitas.2025.108782
Petra Stute , Marla Shapiro C.M. , Antonia Morga , Ting-an Tai , Mayank Ajmera , Bogdan Muresan , Karla Martins , Yechu Hua , Angela Zhao , Jingyi Liu , Rossella E. Nappi

Objectives

Vasomotor symptoms (VMS) are a burden for women in menopause. Despite the availability of hormone therapy (HT), many cannot or do not wish to utilise it. The efficacy of the neurokinin receptor antagonists fezolinetant and elinzanetant has been established in clinical trials. Matching-adjusted indirect comparison (MAIC), which controls for the differences in treatment effect modifiers between trials and provides robust estimates of relative treatment effects, was used here to compare the efficacy of fezolinetant and elinzanetant in individuals with VMS associated with menopause.

Study design

Patient-level data from the fezolinetant SKYLIGHT-1/2 trials were used to match the population and study design of elinzanetant OASIS-1/2 trials. Treatment effect modifiers were identified and MAIC analyses were performed.

Main outcome measures

VMS frequency and severity, Patient-Reported Outcomes Measurement Information System Sleep Disturbance – Short Form 8b (PROMIS SD SF 8b), Menopause Specific Quality of Life Questionnaire (MENQOL).

Results

The OASIS-1/2 trial populations had higher mean VMS frequency/severity and greater sleep disturbance at baseline. Fezolinetant and elinzanetant had comparable efficacy in reducing VMS frequency and severity. Sleep disturbance improved with both drugs but more with elinzanetant. Improvement in sleep disturbance did not translate into a significant difference in overall QoL, as measured by MENQOL.

Conclusions

MAIC analysis found that fezolinetant and elinzanetant had a similar efficacy profile for reduction of VMS frequency and severity. Differences in reduction of sleep disturbances did not result in differences in QoL. Neurokinin receptor antagonists provide an alternative to HT and other non-HT options for the treatment of VMS associated with menopause.
目的:血管舒缩症状(VMS)是绝经期妇女的负担。尽管有激素治疗(HT),但许多人不能或不愿使用它。神经激肽受体拮抗剂非唑啉奈坦和依兰那坦的疗效已在临床试验中得到证实。匹配调整间接比较(MAIC),控制试验之间治疗效果调节剂的差异,并提供相对治疗效果的可靠估计,用于比较fezolinetant和elinzanetant对绝经期VMS患者的疗效。研究设计:使用氟唑尼坦SKYLIGHT-1/2试验的患者水平数据来匹配氟唑尼坦OASIS-1/2试验的人群和研究设计。确定治疗效果调节剂并进行MAIC分析。主要结果测量:VMS频率和严重程度,患者报告的结果测量信息系统睡眠障碍短表8b (PROMIS SD SF 8b),更年期特定生活质量问卷(MENQOL)。结果:OASIS-1/2试验人群在基线时有更高的平均VMS频率/严重程度和更大的睡眠障碍。非唑啉奈坦和依兰奈坦在降低VMS频率和严重程度方面具有相当的疗效。两种药物均能改善睡眠障碍,但依兰那坦效果更好。睡眠障碍的改善并没有转化为MENQOL测量的总体生活质量的显著差异。结论:MAIC分析发现,fezolinetant和elinzanetant在降低VMS频率和严重程度方面具有相似的疗效。睡眠障碍减少的差异并没有导致生活质量的差异。神经激肽受体拮抗剂为治疗与更年期相关的VMS提供了一种替代HT和其他非HT的选择。
{"title":"Fezolinetant compared with elinzanetant for the treatment of vasomotor symptoms associated with menopause: A matching-adjusted indirect comparison","authors":"Petra Stute ,&nbsp;Marla Shapiro C.M. ,&nbsp;Antonia Morga ,&nbsp;Ting-an Tai ,&nbsp;Mayank Ajmera ,&nbsp;Bogdan Muresan ,&nbsp;Karla Martins ,&nbsp;Yechu Hua ,&nbsp;Angela Zhao ,&nbsp;Jingyi Liu ,&nbsp;Rossella E. Nappi","doi":"10.1016/j.maturitas.2025.108782","DOIUrl":"10.1016/j.maturitas.2025.108782","url":null,"abstract":"<div><h3>Objectives</h3><div>Vasomotor symptoms (VMS) are a burden for women in menopause. Despite the availability of hormone therapy (HT), many cannot or do not wish to utilise it. The efficacy of the neurokinin receptor antagonists fezolinetant and elinzanetant has been established in clinical trials. Matching-adjusted indirect comparison (MAIC), which controls for the differences in treatment effect modifiers between trials and provides robust estimates of relative treatment effects, was used here to compare the efficacy of fezolinetant and elinzanetant in individuals with VMS associated with menopause.</div></div><div><h3>Study design</h3><div>Patient-level data from the fezolinetant SKYLIGHT-1/2 trials were used to match the population and study design of elinzanetant OASIS-1/2 trials. Treatment effect modifiers were identified and MAIC analyses were performed.</div></div><div><h3>Main outcome measures</h3><div>VMS frequency and severity, Patient-Reported Outcomes Measurement Information System Sleep Disturbance – Short Form 8b (PROMIS SD SF 8b), Menopause Specific Quality of Life Questionnaire (MENQOL).</div></div><div><h3>Results</h3><div>The OASIS-1/2 trial populations had higher mean VMS frequency/severity and greater sleep disturbance at baseline. Fezolinetant and elinzanetant had comparable efficacy in reducing VMS frequency and severity. Sleep disturbance improved with both drugs but more with elinzanetant. Improvement in sleep disturbance did not translate into a significant difference in overall QoL, as measured by MENQOL.</div></div><div><h3>Conclusions</h3><div>MAIC analysis found that fezolinetant and elinzanetant had a similar efficacy profile for reduction of VMS frequency and severity. Differences in reduction of sleep disturbances did not result in differences in QoL. Neurokinin receptor antagonists provide an alternative to HT and other non-HT options for the treatment of VMS associated with menopause.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"205 ","pages":"Article 108782"},"PeriodicalIF":3.6,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex differences in the relationship between dynapenic abdominal obesity and the risk of motoric cognitive risk syndrome in older Chinese adults: A national prospective cohort study 中国老年人动态腹部肥胖与运动认知危险综合征风险关系的性别差异:一项全国前瞻性队列研究
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-23 DOI: 10.1016/j.maturitas.2025.108786
Qing Li , Chengxiang Song , Hao Zhou , Junli Li , Mao Chen

Objectives

Dynapenic abdominal obesity is associated with adverse health outcomes in older adults. However, the longitudinal relationship between dynapenic abdominal obesity and motoric cognitive risk syndrome, a pre-dementia condition, remains unclear. We aimed to elucidate this association in older males and females.

Methods

A total of 3309 individuals from the 2011 and 2015 waves of the China Health and Retirement Longitudinal Study were enrolled. Individuals were categorized into 4 groups based on sex-specific thresholds for handgrip strength (< 28 kg for males and < 18 kg for females) and waist circumference (≥ 90 cm for males and ≥ 85 cm for females): non-dynapenic/non-abdominal obesity, non-dynapenic/abdominal obesity, dynapenic/non-abdominal obesity and dynapenic/abdominal obesity. Multivariable logistic regression analysis was performed to investigate the relationship between dynapenic abdominal obesity and motoric cognitive risk syndrome risk.

Results

Over a 4-year follow-up, 410 (12.4 %) individuals experienced motoric cognitive risk syndrome. Individuals in the dynapenic/abdominal obesity group exhibited a markedly elevated risk of motoric cognitive risk syndrome as compared with those in the non-dynapenic/non-abdominal obesity group (odds ratio = 2.56, 95 % confidence interval 1.74–3.78, P < 0.001). This association was pronounced among males but not females. Further analyses revealed that the association was primarily driven by dynapenia, whereas abdominal obesity made only a modest contribution in males and showed no effect in females.

Conclusions

Dynapenic abdominal obesity was significantly associated with an increased risk of developing motoric cognitive risk syndrome, especially among older males.
目的:动态腹部肥胖与老年人不良健康结局相关。然而,动力型腹部肥胖与运动认知风险综合征(一种痴呆前期疾病)之间的纵向关系尚不清楚。我们的目的是阐明老年男性和女性的这种关联。方法纳入2011年和2015年中国健康与退休纵向研究的3309名受试者。根据握力(男性28公斤,女性18公斤)和腰围(男性≥90厘米,女性≥85厘米)的性别阈值,将个体分为4组:非动力/非腹部肥胖、非动力/腹部肥胖、动力/非腹部肥胖和动力/腹部肥胖。采用多变量logistic回归分析探讨动态性腹部肥胖与运动认知危险综合征风险的关系。结果在4年的随访中,410人(12.4%)出现运动认知危险综合征。与非动力型/非腹部型肥胖组相比,动力型/腹部型肥胖组的个体出现运动认知危险综合征的风险显著升高(优势比= 2.56,95%可信区间1.74-3.78,P < 0.001)。这种联系在男性中很明显,但在女性中没有。进一步的分析表明,这种关联主要是由动力不足驱动的,而腹部肥胖在男性中只起了适度的作用,在女性中没有表现出任何影响。结论动力型腹部肥胖与运动认知危险综合征发生风险增加显著相关,尤其是在老年男性中。
{"title":"Sex differences in the relationship between dynapenic abdominal obesity and the risk of motoric cognitive risk syndrome in older Chinese adults: A national prospective cohort study","authors":"Qing Li ,&nbsp;Chengxiang Song ,&nbsp;Hao Zhou ,&nbsp;Junli Li ,&nbsp;Mao Chen","doi":"10.1016/j.maturitas.2025.108786","DOIUrl":"10.1016/j.maturitas.2025.108786","url":null,"abstract":"<div><h3>Objectives</h3><div>Dynapenic abdominal obesity is associated with adverse health outcomes in older adults. However, the longitudinal relationship between dynapenic abdominal obesity and motoric cognitive risk syndrome, a pre-dementia condition, remains unclear. We aimed to elucidate this association in older males and females.</div></div><div><h3>Methods</h3><div>A total of 3309 individuals from the 2011 and 2015 waves of the China Health and Retirement Longitudinal Study were enrolled. Individuals were categorized into 4 groups based on sex-specific thresholds for handgrip strength (&lt; 28 kg for males and &lt; 18 kg for females) and waist circumference (≥ 90 cm for males and ≥ 85 cm for females): non-dynapenic/non-abdominal obesity, non-dynapenic/abdominal obesity, dynapenic/non-abdominal obesity and dynapenic/abdominal obesity. Multivariable logistic regression analysis was performed to investigate the relationship between dynapenic abdominal obesity and motoric cognitive risk syndrome risk.</div></div><div><h3>Results</h3><div>Over a 4-year follow-up, 410 (12.4 %) individuals experienced motoric cognitive risk syndrome. Individuals in the dynapenic/abdominal obesity group exhibited a markedly elevated risk of motoric cognitive risk syndrome as compared with those in the non-dynapenic/non-abdominal obesity group (odds ratio = 2.56, 95 % confidence interval 1.74–3.78, <em>P</em> &lt; 0.001). This association was pronounced among males but not females. Further analyses revealed that the association was primarily driven by dynapenia, whereas abdominal obesity made only a modest contribution in males and showed no effect in females.</div></div><div><h3>Conclusions</h3><div>Dynapenic abdominal obesity was significantly associated with an increased risk of developing motoric cognitive risk syndrome, especially among older males.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"204 ","pages":"Article 108786"},"PeriodicalIF":3.6,"publicationDate":"2025-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145618322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between anti-Müllerian hormone, hypertension and vascular age: the Generation R Study, a population-based prospective cohort study 抗<s:1>勒氏激素、高血压和血管年龄的相关性:R世代研究,一项基于人群的前瞻性队列研究
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-20 DOI: 10.1016/j.maturitas.2025.108785
R.H.M. Dykgraaf , S. Schalekamp-Timmermans , S.A.A. van den Berg , E.J. Vinke , E.A.P. Steegers , J.S.E. Laven , Y.V. Louwers

Objective

The objective of this study was to explore the relationship between levels of anti-Müllerian hormone (AMH) and the risk of hypertension and vascular ageing in a population-based cohort.

Study design

This study was embedded in the Generation R Study, a prospective population-based cohort study of children and their parents in the City of Rotterdam, the Netherlands. The present study included all women at the first recall visit with available data on AMH and blood pressure (n = 4883) and analysed the association between AMH and hypertension. AMH levels (first recall visit) and carotid artery intima-medial thickness (CIMT) measurements (second recall visit) were used to analyse the association between AMH serum levels and CIMT as a proxy for vascular age (n = 3508).

Results

A higher age and lower AMH percentiles (adjusted for age) were associated with an increased risk of hypertension. Women with AMH percentiles <p10 had a 2.1 times higher risk of hypertension than women with AMH levels >p90 (P < .001). Vascular age, conducted from CIMT measurements (second recall visit), was on average 9.8 years older than chronological age in those with an AMH below p10 (first recall visit). This difference was 6.1 years in those with an AMH exceeding p90. Similarly, differences in medians between the groups were significant (p < 0,008).

Conclusions

This large prospective cohort study shows that low AMH levels later in life, independent of age, are associated with hypertension. The results indicate that diminished ovarian reserve at a younger age is associated with indicators of vascular alterations. Women with low AMH levels should not only be counseled about potential fertility issues, but should also be informed about their increased risk of vascular damage in order to take appropriate preventive measures. In the future, AMH may serve as a prospective marker for the early detection of cardiovascular diseases.
本研究的目的是在以人群为基础的队列中探讨抗勒氏管激素(AMH)水平与高血压和血管老化风险之间的关系。研究设计本研究是R世代研究的一部分,这是一项针对荷兰鹿特丹市儿童及其父母的前瞻性人群队列研究。本研究纳入了所有在第一次回顾就诊时具有AMH和血压可用数据的妇女(n = 4883),并分析了AMH和高血压之间的关系。AMH水平(第一次回忆访诊)和颈动脉内膜-内侧厚度(CIMT)测量(第二次回忆访诊)被用来分析AMH血清水平和CIMT作为血管年龄的代表之间的关系(n = 3508)。结果较高的年龄和较低的AMH百分位数(经年龄调整)与高血压风险增加相关。AMH百分位数为p10的女性患高血压的风险是AMH水平为p90的女性的2.1倍(P < .001)。通过CIMT测量(第二次回顾访视),AMH低于p10(第一次回顾访视)的患者血管年龄平均比实足年龄大9.8岁。在AMH超过p90的患者中,这一差异为6.1年。同样,两组间的中位数差异也很显著(p < 0,008)。结论:这项大型前瞻性队列研究表明,晚年低AMH水平与高血压有关,与年龄无关。结果表明,卵巢储备在年轻时减少与血管改变的指标有关。AMH水平低的妇女不仅应该被告知潜在的生育问题,而且应该被告知她们血管损伤的风险增加,以便采取适当的预防措施。在未来,AMH可能作为心血管疾病早期检测的前瞻性标志物。
{"title":"Correlation between anti-Müllerian hormone, hypertension and vascular age: the Generation R Study, a population-based prospective cohort study","authors":"R.H.M. Dykgraaf ,&nbsp;S. Schalekamp-Timmermans ,&nbsp;S.A.A. van den Berg ,&nbsp;E.J. Vinke ,&nbsp;E.A.P. Steegers ,&nbsp;J.S.E. Laven ,&nbsp;Y.V. Louwers","doi":"10.1016/j.maturitas.2025.108785","DOIUrl":"10.1016/j.maturitas.2025.108785","url":null,"abstract":"<div><h3>Objective</h3><div>The objective of this study was to explore the relationship between levels of anti-Müllerian hormone (AMH) and the risk of hypertension and vascular ageing in a population-based cohort.</div></div><div><h3>Study design</h3><div>This study was embedded in the Generation R Study, a prospective population-based cohort study of children and their parents in the City of Rotterdam, the Netherlands. The present study included all women at the first recall visit with available data on AMH and blood pressure (<em>n</em> = 4883) and analysed the association between AMH and hypertension. AMH levels (first recall visit) and carotid artery intima-medial thickness (CIMT) measurements (second recall visit) were used to analyse the association between AMH serum levels and CIMT as a proxy for vascular age (<em>n</em> = 3508).</div></div><div><h3>Results</h3><div>A higher age and lower AMH percentiles (adjusted for age) were associated with an increased risk of hypertension. Women with AMH percentiles &lt;p10 had a 2.1 times higher risk of hypertension than women with AMH levels &gt;p90 (<em>P</em> &lt; .001). Vascular age, conducted from CIMT measurements (second recall visit), was on average 9.8 years older than chronological age in those with an AMH below p10 (first recall visit). This difference was 6.1 years in those with an AMH exceeding p90. Similarly, differences in medians between the groups were significant (<em>p</em> &lt; 0,008).</div></div><div><h3>Conclusions</h3><div>This large prospective cohort study shows that low AMH levels later in life, independent of age, are associated with hypertension. The results indicate that diminished ovarian reserve at a younger age is associated with indicators of vascular alterations. Women with low AMH levels should not only be counseled about potential fertility issues, but should also be informed about their increased risk of vascular damage in order to take appropriate preventive measures. In the future, AMH may serve as a prospective marker for the early detection of cardiovascular diseases.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"204 ","pages":"Article 108785"},"PeriodicalIF":3.6,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145618323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Maturitas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1